Bio Medica Laboratories
Key Fundamentals
SMEPharmaceuticals & BiotechnologyHealthcarePrice-based figures as of · TTM
- ROCE
- —
- Debt to Equity
- 1.54
- EPS (TTM)
- —
- Book Value
- ₹58.61
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 2.51
- ROE
- 45.20%
- Dividend Yield
- 0.00%
- EBITDA
- ₹19.70 Cr
- 52W High
- ₹181.00
- 52W Low
- ₹101.50
- Day Range
- ₹147.00 – ₹147.00
- Volume
- 1,000
Peer Comparison
Healthcare › Pharmaceuticals
| ₹1,773.40 | 38.81 | ₹4,29,049 Cr | 4.77 | 0.90% | 16.00% | 20.50% | ₹61,631 Cr | ₹10,987 Cr | |
| ₹10,037.50 | 91.10 | ₹2,65,269 Cr | 15.90 | 0.30% | 16.50% | 22.00% | ₹11,230 Cr | ₹2,925 Cr | |
| ₹4,738.50 | 78.61 | ₹1,77,061 Cr | 9.81 | 0.82% | 27.40% | 15.20% | ₹17,400 Cr | ₹2,099 Cr | |
| ₹1,188.10 | 26.44 | ₹1,25,446 Cr | 4.37 | 0.08% | 21.20% | 21.10% | ₹28,592 Cr | ₹4,593 Cr | |
| ₹2,323.80 | 114.81 | ₹1,25,228 Cr | 20.72 | 0.04% | 18.30% | 17.80% | ₹7,270 Cr | ₹1,090 Cr | |
| ₹1,374.00 | 35.59 | ₹1,14,543 Cr | 2.96 | 0.58% | 11.20% | 13.00% | ₹33,228 Cr | ₹3,184 Cr | |
| ₹1,402.00 | 33.59 | ₹1,12,454 Cr | 3.20 | 0.93% | 11.60% | 15.50% | ₹28,324 Cr | ₹3,356 Cr | |
| Bio Medica Laboratories (this company) | ₹147.00 | — | ₹181 Cr | 2.51 | 0.00% | 45.20% | — | — | — |
| Median 8 companies | ₹1,587.70 | 38.81 | ₹1,25,337 Cr | 4.57 | 0.44% | 17.40% | 17.80% | ₹28,324 Cr | ₹3,184 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 9 | 7 | 3 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 7 | 2 | 1 |
Oscillators
Neutral
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 44.13
- Neutral
- MACD (12,26,9)
- −3.16
- Bearish
- SMA (50)
- 156.53
- Bearish
- SMA (200)
- —
- Neutral
As of
Growth Rate
Annual windows: Fewer than two fiscal years are reported, so there is no annual growth yet.
Trailing twelve months: Fewer than eight quarters are reported, so there is no trailing-twelve-month figure.
Quarterly Results
₹ Cr| Particulars | Mar 2026 |
|---|---|
| Sales | 43 |
| Expenses | 23 |
| Operating Profit | 20 |
| OPM % | 46% |
| Other Income | 0 |
| Interest | 2 |
| Depreciation | 1 |
| PBT | 16 |
| Tax % | 27% |
| Net Profit | 12 |
| EPS (₹) | 13.06 |
Profit & Loss
₹ Cr| Particulars | Mar 2026 |
|---|---|
| Sales | 43 |
| Expenses | 23 |
| Operating Profit | 20 |
| OPM % | 46% |
| Other Income | 0 |
| Interest | 2 |
| Depreciation | 1 |
| PBT | 16 |
| Tax % | 27% |
| Net Profit | 12 |
| EPS (₹) | 13.06 |
| Div. Payout % | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2026 |
|---|---|
| Equity Capital | 9 |
| Reserves | 17 |
| Borrowings | 40 |
| Other Liabilities | 7 |
| Total Liabilities | 73 |
| Fixed Assets | 17 |
| CWIP | 0 |
| Investments | 0 |
| Other Assets | 56 |
| Total Assets | 73 |
Cash Flow
₹ Cr| Particulars | Mar 2026 |
|---|---|
| Operating | −6 |
| Investing | −2 |
| Financing | 8 |
| Net Cash Flow | 0 |
| Free Cash Flow | −8 |
| CFO/OP | −9 |
Ratios
| Particulars | Mar 2026 |
|---|---|
| Debtor Days | 92 |
| Inventory Days | 759 |
| Days Payable | 116 |
| Cash Conversion Cycle | 735 |
| Working Capital Days | 300 |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Bio Medica Laboratories insights
44 extracted metrics across FY25–FY26.
Documents
- 29 Sep 2026
- 28 Sep 2026
- 28 Sep 2026
- 22 Sep 2026
Frequently Asked Questions about Bio Medica Laboratories
What does Bio Medica Laboratories Ltd do?
Where is Bio Medica Laboratories Ltd (BMLL) listed?
Which sector does Bio Medica Laboratories Ltd belong to?
What is the 52-week high and low of Bio Medica Laboratories Ltd?
What is the Return on Equity (ROE) of Bio Medica Laboratories Ltd?
Company Information
Incorporated in August 2015, Bio Medica Laboratories Ltd specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the -counter (OTC) medications
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/BMLL.md for Bio Medica Laboratories Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.